3860 — EPS Creative Health Technology Cashflow Statement
0.000.00%
- HK$349.46m
- HK$274.21m
- HK$457.65m
Annual cashflow statement for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.7 | -48.2 | -24.1 | 33.4 | -7.52 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5.14 | 5.61 | -10 | -39.2 | 7.84 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18 | -0.034 | -8.49 | -27.9 | 11 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.02 | -38.1 | -28.6 | -17.9 | 28.2 |
| Capital Expenditures | -0.283 | -2.41 | -5.04 | -5.71 | -3.09 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.63 | -8.97 | -15.4 | 62.9 | 0.113 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.35 | -11.4 | -20.4 | 57.2 | -2.98 |
| Financing Cash Flow Items | 115 | -24.7 | 29.7 | -31.3 | -26.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 112 | -27.8 | 33.7 | -16.8 | -37.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 123 | -76.7 | -15.9 | 20.2 | -9.2 |